Blood pressure is the force of blood pushing against artery walls, and its regulation is vital for preventing heart disease, stroke and kidney damage. Research shows that both very high and very low blood pressure can be harmful, and optimal levels may differ by age and individual risk factors.

Hypertension often develops silently over years. Studies link sustained high pressure with damage to blood vessels, enlargement of the heart and reduced blood flow to organs. Large population studies demonstrate a continuous relationship between higher systolic and diastolic values and increased risk of cardiovascular events, even within ranges previously considered “borderline.”

Clinical trials of blood pressure lowering therapies demonstrate that reducing pressure reduces risk, but not always in a simple linear fashion. Evidence from intensive treatment trials suggests that, for some patients, targeting lower systolic values significantly cuts rates of heart attack, stroke and cardiovascular death. However, aggressive lowering can also increase side effects such as fainting, kidney problems and electrolyte disturbances, particularly in older or frail individuals.

Research emphasizes that method of measurement matters. Office readings can differ from home or ambulatory measurements, leading to misclassification. White coat and masked hypertension highlight the importance of repeated and varied measurements to accurately assess risk and guide treatment.

Lifestyle interventions such as reducing salt intake, maintaining healthy weight, engaging in regular physical activity and moderating alcohol consumption are consistently associated with lower blood pressure and reduced cardiovascular risk. Medications remain essential for many, and ongoing research focuses on tailoring targets and treatments to individual risk profiles rather than using a single universal threshold.